Sort by
Refine Your Search
-
Category
-
Program
-
Employer
-
Field
-
The Institute for Digestive Research at the Lithuanian University of Health Sciences (LSMU) invites applications for a full-time appointment as the rank of Group Leader position in the field of host
-
Group Leaders and Postdoctoral Researchers: Global Call for Scientific Talent at Fondazione Telethon
science, translational research and clinical application. Our research ecosystem — which includes world-recognized centres of excellence such as TIGEM (Telethon Institute of Genetics and Medicine) in
-
Engineering Risk and Complexity (MERC) Program duration: 4 years No. of scholarships: 5 Coordinator: Prof. Mario di Bernardo Contact e-mail: merc@ssmeridionale.it 9. Molecular Sciences for Earth and Space
-
needs of students, employers, and society in a world that is changing faster than ever before. More than a business school, Hult is a dynamic and multicultural community that educates, inspires, and
-
The Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences (IOCB Prague) invites applications for a tenure-track Junior Group Leader position in Biosciences with strong
-
EMBL provides a unique environment for young scientists to conduct ground-breaking research and technology development across the life sciences. We recruit early career research leaders, granting
-
Hospital. It hosts the residency and PhD programs of Humanitas University , a life science university that stands out for its real-world simulation-based approach to medical training and its international
-
. This requires not only pushing the boundaries of research, but also translating these advancements into robotic technology that stand the challenge of the real-world application. To accomplish this mission
-
for young scientists to conduct ground-breaking research and technology development across the life sciences. The EMBL Epigenetics & Neurobiology Unit, located near Rome, Italy, applies a wide range of
-
(Lanna et al., Nature Cell Biology, 2022). On this basis, we introduced the "DOS", which- to date- represents the first drug in the world capable of reversing T cell aging resulting in immune remodelling